Utilization Requirements Clause Samples
Utilization Requirements. 1. Harvesting shall proceed in an orderly manner from the back of the lot to the front, or in an equivalent manner which will ensure completion of cutting in all areas designated for harvest. Only wood designated by the Seller/Seller’s agent shall be harvested.
2. All marked or otherwise designated wood, including defective trees, must be cut.
3. ▇▇▇▇▇ heights shall not exceed six (6) inches, except where obvious obstacles, problems with terrain, swell of roots, or similar hindrances do not permit such a low cut. Snow shall be removed as necessary to comply with this requirement.
4. All trees are to be limbed and cut off at the top end so that no part of any felled trees which will make merchantable product shall be left in the ▇▇▇▇▇ unutilized.
5. Small end diameter shall not be less than the minimums specified below for the indicated types of wood and product. ______________________________________________________________________________ ______________________________________________________________________________ ______________________________________________________________________________
Utilization Requirements. 1. Harvesting shall proceed in an orderly manner from the back of the lot to the front or in an equivalent manner to completion of cutting in all areas designated for harvest. Only wood designated by the Seller's agent shall be harvested.
2. Small end diameter shall not be less than the minimums specified by purchasing ▇▇▇▇▇ for types of wood and product.
Utilization Requirements. If Auxilium exercises its option rights under the Auxilium License Agreement in respect of Cellulite, then BTC agrees to enforce its rights under the Auxilium License Agreement for the benefit of BTC and the Research Foundation hereunder. If Auxilium does not exercise its option rights under the Sublicense Agreement in respect of Cellulite, then BTC agrees that, within two (2) years of the date on which Auxilium notifies BTC that it does not intend to exercise its option rights under the Auxilium License Agreement, BTC shall either (i) enter into a new sublicense agreement in respect of Cellulite or (ii) submit to the FDA a clinical trial protocol to initiate on its own a further clinical trial (whether Phase 2b or Phase 3) in respect of Cellulite and obtain a commitment from a reputable third-party of no less than $1 million dollars to fund such further clinical trial.